Stay updated on Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial

Sign up to get notified when there's something new on the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A notice appears above the page stating that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and linking to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T04:22:53.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T03:50:04.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The clinical trial study record has been replaced by a 403 Forbidden error page.
    Difference
    17%
    Check dated 2026-10-11T08:14:53.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The study record is displayed with its design, quizartinib and salvage-chemotherapy arms, outcomes, eligibility criteria, locations, and data-sharing information.
    Difference
    100%
    Check dated 2026-10-04T08:18:45.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the expected study record content with a standard error page. As a result, essential study information is not accessible on this page.
    Difference
    17%
    Check dated 2026-09-20T02:24:15.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, indicating a small release likely for UI or maintenance. It does not appear to modify the study details.
    Difference
    0.0%
    Check dated 2026-08-29T23:51:27.000Z thumbnail image

Stay in the know with updates to Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page.